Advertisement

Allergy-friendly company to hit growth spurt through partnership

Sweets from the Earth logo over background of its allergy-friendly baked goods
GRAPHIC COLLAGE BY AVANT FOOD MEDIA
BY: Maddie Lambert

Maddie Lambert

TORONTO — Fengate Private Equity, a division of Fengate Asset Management, announced a partnership with Sweets from the Earth, a leading manufacturer of allergy-friendly sweet goods, to further support the growth of the business throughout North America.

The acquisition represents Fengate’s second platform investment in the food and beverage sector within the past 18 months. Sweets from the Earth’s co-CEOs Ilana Kadonoff and Marc Kadonoff will retain a significant minority stake and will lead the business in partnership with Fengate.

Advertisement

“We are thrilled to partner with Fengate as we enter the next chapter of the Sweets from the Earth growth story,” Ilana Kadonoff said. “Fengate was a natural fit from a partnership perspective and shares both our entrepreneurial spirit and our vision for creating greater access to great-tasting, plant-based, allergy-friendly food products.”

Founded in 2002, Sweets from the Earth produces a full line of egg- and dairy-free baked goods, which are 100% plant-based and crafted with all-natural, responsibly sourced, kosher and halal ingredients. The company also offers nut- and gluten-free product lines.

Advertisement

“We are excited to partner with Ilana and Marc and support the next phase of growth at Sweets from the Earth,” said Jennifer Pereira, managing director for Fengate Private Equity. “[Sweets from the Earth] has established a market-leading position through its truly unique product offering, which has been built on many years of quality and innovation. They are a perfect fit with our strategy of backing strong management teams with ample runway for growth, and we’re proud to support Canadian entrepreneurs and brands.”

Fengate is managing this investment on behalf of the LiUNA Pension Fund of Central and Eastern Canada.

Advertisement

Related News

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles